Incyte Corp (FRA:ICY)
€ 49.53 -0.85 (-1.69%) Market Cap: 11.18 Bil Enterprise Value: 7.64 Bil PE Ratio: 16.22 PB Ratio: 2.23 GF Score: 84/100

Incyte Corp at BMO Capital Markets Prescription for Success Healthcare Conference (Virtual) Transcript

Jun 23, 2020 / 05:30PM GMT
Release Date Price: €96.76 (+0.58%)
George Farmer
BMO Capital Markets Equity Research - Analyst

Hi. Hello, everyone. Good afternoon. Welcome to our afternoon session of the Virtual BMO Healthcare Conference. I'm George Farmer, Senior Biotechnology Analyst at BMO. It's my pleasure to have the management team of Incyte with us this afternoon, and we're going to talk about company progress. We have with us the CEO, Hervé Hoppenot; and the CFO, Christiana Stamoulis. We're going to have a fireside chat with both of them. Thank you very much for being here.

HervÃ;Hoppenot
Incyte Corporation - Chairman, President & CEO

© -

Well, thank you for inviting us.

Questions & Answers

George Farmer
BMO Capital Markets Equity Research - Analyst

Yes, wonderful. So perhaps we can just start on a high level and talk about flagship product, Jakafi. You have provided us with some very bullish sales guidance, 2020 sales guidance of $1.88 billion to $1.95 billion this year that you maintained on your quarterly call. Can you tell us about your

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot